All In Biotech

Free tool

FAERS Monitor: Tlando

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208088 or its brand name (Tlando, Testosterone Undecanoate). Reports on generic versions are filed under their own applications.

Reports

250

Serious

208

83% of reports

Hospitalization

95

Death reported

20

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use31
  • drug abuse13
  • atrial fibrillation10
  • drug ineffective10
  • asthma9
  • erectile dysfunction9
  • fatigue9
  • weight decreased9
  • duodenal ulcer8
  • erosive duodenitis8
  • faeces discoloured8
  • pneumonia haemophilus8
  • polycythaemia8
  • product use in unapproved indication8
  • pyrexia8

Reports by year received

View as table
YearReports
20042
20051
20061
20093
20106
20112
20129
20135
20144
201512
20167
20175
201822
20198
20209
202114
202212
202323
202433
202542
202630

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,909 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pneumonia haemophilusSignal81409.5708.69,733
erosive duodenitisSignal8850.7428.75,907
polycythaemiaSignal8327.5165.42,279
duodenal ulcerSignal895.548.3656
faeces discolouredSignal831.115.7204
erectile dysfunctionSignal929.515.5220
drug abuseSignal1313.17.7134
atrial fibrillationSignal108.64.760
asthmaSignal96.73.538
off label useSignal313.02.140
product use in unapproved indicationSignal82.71.47
weight decreasedSignal92.71.48
pyrexia81.91.03
fatigue91.00.50
drug ineffective100.60.32

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.